Clinical trial · Interventional
Invitro Maturation of Oocytes for Patients With Polycystic Ovaries
In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries
NCT00631982CI-TRIAL-00001336unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Infertility | — | UNRESOLVED | — |
| Polycystic Ovaries | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| in vitro matuartion of oocytes | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Group I
- description
- patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
- interventionNames
- Procedure: in vitro matuartion of oocytes
Primary outcomes (1)
- measure
- maturation rate,
- timeFrame
- 18 months
Secondary outcomes (1)
- measure
- Fertilization rate, pregnancy rate
- timeFrame
- 18 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * Polycystic ovaries * Needing IVF for fertility treatment Exclusion Criteria: * Age above 39
References
Publications (0)
Data not yet available
No reference posted for this study.